David Wojciechowski
University of Texas Southwestern Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name David Wojciechowski as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:38 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT06958796 · Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV)Camille N. Kotton, MD · recruiting · Cytomegalovirus, Organ Transplant, Kidney Transplant; Complications · principal investigator
- N/ANCT06336863 · Use of DNA Testing and Gene Expression Profiling to Help Transition Kidney Transplant Recipients to Belatacept-only ImmunosuppressionUniversity of Texas Southwestern Medical Center · enrolling by invitation · Kidney Transplant Immunosuppression · principal investigator
- Ph4NCT04786067 · Use of DNA Testing to Help Transition Kidney Transplant Recipients to Belatacept-only ImmunosuppressionUniversity of Texas Southwestern Medical Center · completed · Kidney Transplant Immunosuppression · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:38 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:38 UTC. The ranking covers the 200 most relevant of 10 PubMed records, and a shared surname and initials can bring in a namesake. All 10 on PubMed
- Defibrillator implantation early after myocardial infarction.N Engl J Med · 2009514 citationsRCR 12.5
- Posoleucel in Kidney Transplant Recipients with BK Viremia: Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.J Am Soc Nephrol · 202428 citationsRCR 5.3
- 26 citationsRCR 0.7
- Mycophenolate Mofetil Withdrawal With Conversion to Everolimus to Treat BK Virus Infection in Kidney Transplant Recipients.Transplant Proc · 201721 citationsRCR 1.2
- Dual costimulation blockade with the CD154-specific fusion protein dazodalibep and belatacept for prophylaxis of kidney allograft rejection.Am J Transplant · 20267 citationsRCR 3.5
- HIV-Positive Liver Transplant Does not Alter the Latent Viral Reservoir in Recipients With Antiretroviral Therapy-Suppressed HIV.J Infect Dis · 20235 citationsRCR 0.5
- Phase 2, Randomized, Double-blind, Placebo-controlled Study of Fiztasovimab (NPC-21) for Kidney Transplant Recipients at High Risk of Cytomegalovirus Infection (LionHeart21).Transplantation · 20253 citationsRCR 1.1
- Tacrolimus to belatacept conversion in proteinuric kidney transplant recipients.Front Immunol · 20242 citationsRCR 0.4
- [The value of the head-up tilt table test for with unexplained syncope in children and young adolescents].Med Wieku Rozwoj · 19990 citationsRCR 0.0